Prepared for demand surge in glass vials for Covid-19 vaccine supply: Vice-Chairman, Piramal Glass – ET HealthWorld

In an interaction with ETHealthworld, Vijay Shah, Vice-Chairman, Piramal Glass, shares the preparedness towards ramping up vials manufacturing and expansion plans of the company. Edited excerpts

Q: How is Piramal Glass gearing for the surge in vials manufacturing for Covid-19 vaccine?
The world is responding to the unprecedented Covid-19 pandemic, with urgency and purpose. World over, pharmaceutical companies are working tirelessly to find a solution to the global health crisis faced by humankind due to Covid-19. In this environment, we are ramping up our vials (Type 1/ Moulded Vials) production in anticipation of the demand for COVID-19 vaccine supply.

We have taken proactive measures to prepare ourselves to meet any surge in demand for glass vials from the pharmaceutical industry across the globe. Various safety measures such as the meticulous implementation of safety precautions, intensified care across our global manufacturing plants, have ensured delivery of safe products to our customers across geographies.

Q: How has functioning of Piramal glass been impacted during and post Covid-19 lockdown?
We at Piramal Glass remain entirely functional and continue to provide services and timely delivery to pharma companies. We are able to cater to all their requirements and are also geared up to meet any spike in demand for glass packaging solutions.

Even during lockdown, our manufacturing facilities remained operational. Our manufacturing, operations, employees and contractors, were exempted because as a contributor to the food and pharma industry, our operations were considered essential services.

Our plant in the US that manufactures bottles and packaging material for essential food products was fully operational supporting the community at large.

Our plants in India – Kosamba and Jambusar were operating under special permissions and employees were taking extra efforts commuting to the office while taking necessary precautions to ensure the safety of all staff members and the environment.

Our Sri Lanka team operated the plant in curfew situations and made all possible efforts for the safety of assets.

We also started manufacturing glass bottles for hand sanitizers in various sizes ranging from 50 ml to 500 ml.

Q: What are the growth plans of Piramal Glass going forward?
Piramal Glass remains committed to supporting pharma companies by addressing their requirements and catering to the current surge in demand for vials. Going forward, if required Piramal Glass is also equipped to add more production capacity to meet the new market demand. Piramal Glass has 45 TPD dedicated capacity for Type I glass at Kosamba, India. In addition, we have allocated a furnace with a capacity of 45 TPD for Type I glass as backup.

Post Covid-19, we are aiming to expand our product mix into premium liquor, premium water – both for commercial and for household requirements. We will also expand into household jars in the premium category.

Source link

Post Author: HealthnMeds

Leave a Reply

Your email address will not be published. Required fields are marked *